SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Cosendai Gregoire (Last) (First) (Middle) 12744 SAN FERNANDO ROAD SUITE 400 (Street) SYLMAR CA 91342 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP Clinical Affairs
	3. Date of Earliest Transaction (Month/Day/Year) 01/04/2018
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								23,484(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$2.06	01/04/2018		A		65,000		01/04/2019(2)	01/04/2028	Common Stock	65,000	(6)	65,000	D
Warrant to Purchase Common Stock	$1.47							03/14/2017	03/14/2022	Common Stock	3,366		3,366	D
Non-Qualified Stock Option (right to buy)	$1.97							01/03/2018(3)	01/03/2027	Common Stock	228,190		228,190	D
Non-Qualified Stock Option (right to buy)	$4.1							01/21/2017(3)	01/21/2026	Common Stock	11,513		11,513	D
Non-Qualified Stock Option (right to buy)	$5							11/01/2009(4)	11/01/2018	Common Stock	20,000		200,000	D
Non-Qualified Stock Option (right to buy)	$5							02/01/2010(4)	02/01/2019	Common Stock	5,081		5,081	D
Non-Qualified Stock Option (right to buy)	$5							05/01/2010(4)	05/01/2019	Common Stock	10,000		10,000	D
Non-Qualified Stock Option (right to buy)	$5							02/01/2011(4)	02/01/2020	Common Stock	14,475		14,475	D
Non-Qualified Stock Option (right to buy)	$5							06/01/2011(4)	06/01/2020	Common Stock	2,125		2,125	D
Non-Qualified Stock Option (right to buy)	$5							12/01/2011(5)	12/01/2020	Common Stock	25,000		25,000	D
Non-Qualified Stock Option (right to buy)	$5							03/01/2012(5)	03/01/2021	Common Stock	6,650		6,650	D
Non-Qualified Stock Option (right to buy)	$5							03/01/2013(5)	03/01/2022	Common Stock	7,750		7,750	D
Non-Qualified Stock Option (right to buy)	$5							04/01/2015(5)	04/01/2024	Common Stock	10,937		10,937	D
Non-Qualified Stock Option (right to buy)	$9							09/26/2015(5)	09/26/2024	Common Stock	51,009		51,009	D
Non-Qualified Stock Option (right to buy)	$13.09							03/26/2016(5)	03/25/2025	Common Stock	6,250		6,250	D

Explanation of Responses:

1. Shares acquired as part of scheduled ESPP purchases.

2. The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.

3. Options vest over a four year term of which one-fourth vest on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.

4. Options vest in 5 yearly increments starting with the Date Exercisable

5. Options vest in 4 yearly increments starting with the Date Exercisable

6. Not Applicable

	Gregoire Cosendai	01/08/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.